Berkshire Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61M Sell
249,741
-1,406
-0.6% -$327K 2.62% 7
2025
Q4
$52M Sell
251,147
-2,435
-1% -$482K 2.28% 10
2025
Q3
$47M Sell
253,582
-837
-0.3% -$143K 2% 15
2025
Q2
$38.9M Sell
254,419
-839
-0.3% -$129K 1.76% 20
2025
Q1
$39.7M Buy
255,258
+3,084
+1% +$483K 1.9% 19
2024
Q4
$37M Sell
252,174
-9,094
-3% -$1.41M 1.75% 23
2024
Q3
$38.2M Hold
261,268
1.94% 17
2024
Q2
$38.2M Buy
261,268
+10,337
+4% +$1.54M 1.9% 18
2024
Q1
$39.7M Sell
250,931
-106
-0% -$16.9K 2.1% 13
2023
Q4
$39.3M Sell
251,037
-1,427
-0.6% -$219K 2.24% 12
2023
Q3
$39.3M Sell
252,464
-1,514
-0.6% -$250K 2.45% 10
2023
Q2
$42M Buy
253,978
+3,983
+2% +$643K 2.49% 11
2023
Q1
$38.7M Sell
249,995
-1,371
-0.5% -$221K 2.39% 13
2022
Q4
$44.4M Buy
251,366
+7,890
+3% +$1.36M 2.85% 7
2022
Q3
$39.8M Sell
243,476
-5,869
-2% -$993K 2.82% 7
2022
Q2
$44.3M Buy
249,345
+4,513
+2% +$804K 2.89% 7
2022
Q1
$43.4M Buy
244,832
+3,748
+2% +$638K 2.74% 10
2021
Q4
$41.2M Buy
241,084
+1,006
+0.4% +$165K 2.51% 10
2021
Q3
$38.8M Buy
240,078
+2,377
+1% +$406K 2.59% 7
2021
Q2
$39.2M Buy
237,701
+16,482
+7% +$2.73M 2.65% 8
2021
Q1
$36.4M Sell
221,219
-10,048
-4% -$1.63M 2.7% 8
2020
Q4
$36.4M Buy
231,267
+18,677
+9% +$2.76M 2.8% 5
2020
Q3
$31.6M Sell
212,590
-11,842
-5% -$1.75M 3.06% 4
2020
Q2
$31.6M Buy
224,432
+3,756
+2% +$547K 2.9% 7
2020
Q1
$28.9M Buy
220,676
+6,338
+3% +$899K 3.01% 5
2019
Q4
$31.3M Sell
214,338
-3,206
-1% -$435K 2.66% 7
2019
Q3
$28.1M Sell
217,544
-8,555
-4% -$1.13M 2.42% 7
2019
Q2
$31.5M Sell
226,099
-3,979
-2% -$551K 2.61% 5
2019
Q1
$32.2M Sell
230,078
-563
-0.2% -$75.4K 2.73% 5
2018
Q4
$29.8M Buy
230,641
+237
+0.1% +$33.1K 2.78% 5
2018
Q3
$31.8M Buy
230,404
+6,872
+3% +$913K 2.7% 6
2018
Q2
$27.1M Buy
223,532
+2,225
+1% +$278K 2.54% 8
2018
Q1
$28.4M Buy
221,307
+4,876
+2% +$659K 2.75% 5
2017
Q4
$30.2M Buy
216,431
+17,005
+9% +$2.37M 2.93% 5
2017
Q3
$25.9M Buy
199,426
+513
+0.3% +$68K 2.89% 4
2017
Q2
$26.3M Buy
198,913
+8,776
+5% +$1.12M 2.99% 3
2017
Q1
$23.7M Buy
190,137
+7,540
+4% +$901K 2.81% 5
2016
Q4
$21M Buy
182,597
+2,499
+1% +$289K 2.72% 5
2016
Q3
$21.3M Buy
180,098
+1,709
+1% +$207K 3.06% 3
2016
Q2
$21.6M Sell
178,389
-2,075
-1% -$236K 3.29% 1
2016
Q1
$19.5M Buy
180,464
+7,160
+4% +$741K 3.04% 4
2015
Q4
$17.8M Buy
173,304
+3,239
+2% +$326K 2.94% 3
2015
Q3
$15.9M Buy
170,065
+1,473
+0.9% +$142K 2.83% 6
2015
Q2
$16.4M Buy
168,592
+3,378
+2% +$338K 2.76% 6
2015
Q1
$16.6M Buy
165,214
+2,867
+2% +$292K 2.78% 7
2014
Q4
$17M Buy
162,347
+7,527
+5% +$793K 2.91% 4
2014
Q3
$16.5M Sell
154,820
-2,024
-1% -$210K 3.04% 4
2014
Q2
$16.4M Sell
156,844
-18,328
-10% -$1.85M 3.05% 4
2014
Q1
$17.2M Sell
175,172
-7,680
-4% -$712K 3.32% 2
2013
Q4
$16.7M Buy
182,852
+30,049
+20% +$2.77M 3.16% 3
2013
Q3
$13.2M Buy
152,803
+11,017
+8% +$988K 3.19% 3
2013
Q2
$12.2M Buy
+141,786
New +$12M 3.37% 3

Other funds holding JNJ

Berkshire Asset Management's JNJ Position: Q1 2026 in Review

Berkshire Asset Management reduced its Johnson & Johnson (JNJ) stake by 0.56% in Q1 2026, selling an estimated $327K and leaving 249,741 shares worth $61M. The position accounts for 2.62% of the portfolio, ranked #7.

Berkshire Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Berkshire Asset Management held 249,741 shares of Johnson & Johnson worth $61M as of Q1 2026.
  • Berkshire Asset Management sold 1,406 Johnson & Johnson shares in Q1 2026, an estimated $327K.
  • Johnson & Johnson made up 2.62% of Berkshire Asset Management's portfolio in Q1 2026, its #7 holding.
  • Berkshire Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.